4-(hydroxyimino)-1,2,3,4-tetrahydropyrimidin-2-one, 95+%, 250mg

6-bromo-2,7-dimethyl-1H,4H-pyrido[2,3-d]pyrimidin-4-one, 98%, 5g

8-Chloro-6-methylquinoline, 95.0%, 250mg

3-Methyl-2-pyrazolin-5-one, 98.0%, 500g

Nickel(II) oxide, min. 75% Ni, pa, black, 400 mesh, 500 g, plastic packaging.

dimethyl bicyclo[2.1.1]hexane-1,4-dicarboxylate, 95.0%, 100mg

4-(3'-Carboxyphenyl)piperidine, 98.0%, 250mg

5'-(3-Carboxyphenyl)-[1,1':3',1''-terphenyl]-3,3''-dicarboxylic acid, 95%, 5g

Ethyl 2-(1,5-dimethyl-1H-pyrazol-4-yl)acetate, 97%, 250mg

N,N-Dimethyl-1-(4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl)methanamine hydrochloride, 97%, 5g

2-(4-((4-Chlorophenyl)(phenyl)methyl)piperazin-1-yl)ethanol dihydrochloride, 97%, 5g

4-Butoxybenzaldehyde>98.0%(GC)25mL

N-(8-Amino-6-fluoro-5-methyl-1-oxo-1,2,3,4-tetrahydronaphthalen-2-yl)acetamide, 97%, 250mg